# SLC25A38

## Overview
SLC25A38 is a gene that encodes the protein solute carrier family 25 member 38, a mitochondrial carrier protein integral to heme biosynthesis. This protein is part of the mitochondrial carrier family, characterized by its transmembrane structure, which facilitates the transport of small molecules such as glycine across the mitochondrial membrane. The transport of glycine is crucial for the synthesis of 5-aminolevulinic acid (ALA), the first precursor in the heme production pathway, particularly in erythroid cells where heme is essential for hemoglobin function. Mutations in the SLC25A38 gene can lead to congenital sideroblastic anemia, a condition marked by ineffective erythropoiesis and mitochondrial iron overload, underscoring the gene's critical role in red blood cell production and iron metabolism (Palmieri2020Diseases; Guernsey2009Mutations).

## Structure
The SLC25A38 protein is a member of the mitochondrial carrier family, characterized by a tripartite structure with six transmembrane alpha-helices. Each of these helices is part of three homologous domains, each containing two hydrophobic regions separated by a hydrophilic sequence, forming a funnel-shaped structure (Palmieri2013The; Pasquadibisceglie2021Computational). This structural arrangement facilitates the transport of small molecules, such as glycine, across the mitochondrial membrane, which is crucial for heme biosynthesis (Palmieri2013The).

The protein's structure includes conserved motifs that form salt bridges, which are essential for the conformational changes required during the transport process (Pasquadibisceglie2021Computational). These motifs are part of the signature sequence PX[D/E]XX[K/R]X[K/R], which is common among mitochondrial carriers (Palmieri2013The). The SLC25A38 protein's function and transport mechanism are influenced by these structural features, although specific details about post-translational modifications or splice variants are not provided in the available context. The exact quaternary structure of SLC25A38 is not detailed, but it is known to operate as a monomer in the transport process (Palmieri2013The).

## Function
The SLC25A38 gene encodes a mitochondrial carrier protein that plays a crucial role in heme biosynthesis by facilitating the transport of glycine into the mitochondrial matrix. In healthy human cells, this protein is essential for the synthesis of 5-aminolevulinic acid (ALA), the first precursor in the heme production pathway. Glycine, transported by SLC25A38, combines with succinyl coenzyme A to form ALA, which is then exported to the cytosol for further processing in heme biosynthesis (Lunetti2016Characterization; Kannengiesser2011Missense).

SLC25A38 is particularly important in erythroid cells, where heme is a critical component of hemoglobin, necessary for oxygen transport in the blood (Palmieri2013The). The protein's activity is localized to the inner mitochondrial membrane, where it may function by importing glycine or exchanging it for ALA, thus maintaining the balance of substrates required for efficient heme synthesis (Kannengiesser2011Missense).

Mutations in SLC25A38 can disrupt this transport function, leading to congenital sideroblastic anemia, characterized by ineffective erythropoiesis and mitochondrial iron overload in erythroblasts (Palmieri2020Diseases; Guernsey2009Mutations). This highlights the gene's vital role in maintaining normal mitochondrial function and iron metabolism in red blood cell production.

## Clinical Significance
Mutations in the SLC25A38 gene are associated with congenital sideroblastic anemia (CSA), a rare disorder characterized by ineffective erythropoiesis and iron accumulation in mitochondria. This condition is typically inherited in an autosomal recessive manner and presents with severe microcytic anemia and systemic iron overload from early childhood. Patients with SLC25A38-related CSA often require regular blood transfusions and iron chelation therapy due to their transfusion dependency and iron overload (Guernsey2009Mutations; Bergmann2009Systematic; Fouquet2019Genotypephenotype).

The most common mutations in SLC25A38 include nonsense, frameshift, and splicing mutations, with a significant number of missense variants occurring at conserved amino acids. These mutations disrupt the gene's function, leading to a form of CSA that is morphologically similar to X-linked sideroblastic anemia but unresponsive to pyridoxine treatment (Ducamp2019The). In the Indian subcontinent, a novel frameshift variant, c.409dupG, has been identified as a prevalent cause of CSA, suggesting a founder effect in this population (Ravindra2020Novel).

Patients with SLC25A38 mutations often exhibit higher ferritin levels and significant liver and myocardial iron overload, necessitating chelation therapy and vitamin B6 supplementation to manage these complications (Fouquet2019Genotypephenotype).


## References


[1. (Lunetti2016Characterization) Paola Lunetti, Fabrizio Damiano, Giuseppe De Benedetto, Luisa Siculella, Antonio Pennetta, Luigina Muto, Eleonora Paradies, Carlo Marya Thomas Marobbio, Vincenza Dolce, and Loredana Capobianco. Characterization of human and yeast mitochondrial glycine carriers with implications for heme biosynthesis and anemia. Journal of Biological Chemistry, 291(38):19746–19759, September 2016. URL: http://dx.doi.org/10.1074/jbc.m116.736876, doi:10.1074/jbc.m116.736876. This article has 67 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1074/jbc.m116.736876)

[2. (Kannengiesser2011Missense) C. Kannengiesser, M. Sanchez, M. Sweeney, G. Hetet, B. Kerr, E. Moran, J. L. Fuster Soler, K. Maloum, T. Matthes, C. Oudot, A. Lascaux, C. Pondarre, J. Sevilla Navarro, S. Vidyatilake, C. Beaumont, B. Grandchamp, and A. May. Missense slc25a38 variations play an important role in autosomal recessive inherited sideroblastic anemia. Haematologica, 96(6):808–813, March 2011. URL: http://dx.doi.org/10.3324/haematol.2010.039164, doi:10.3324/haematol.2010.039164. This article has 48 citations.](https://doi.org/10.3324/haematol.2010.039164)

[3. (Palmieri2020Diseases) Ferdinando Palmieri, Pasquale Scarcia, and Magnus Monné. Diseases caused by mutations in mitochondrial carrier genes slc25: a review. Biomolecules, 10(4):655, April 2020. URL: http://dx.doi.org/10.3390/biom10040655, doi:10.3390/biom10040655. This article has 75 citations and is from a peer-reviewed journal.](https://doi.org/10.3390/biom10040655)

[4. (Guernsey2009Mutations) Duane L Guernsey, Haiyan Jiang, Dean R Campagna, Susan C Evans, Meghan Ferguson, Mark D Kellogg, Mathieu Lachance, Makoto Matsuoka, Mathew Nightingale, Andrea Rideout, Louis Saint-Amant, Paul J Schmidt, Andrew Orr, Sylvia S Bottomley, Mark D Fleming, Mark Ludman, Sarah Dyack, Conrad V Fernandez, and Mark E Samuels. Mutations in mitochondrial carrier family gene slc25a38 cause nonsyndromic autosomal recessive congenital sideroblastic anemia. Nature Genetics, 41(6):651–653, May 2009. URL: http://dx.doi.org/10.1038/ng.359, doi:10.1038/ng.359. This article has 195 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1038/ng.359)

[5. (Bergmann2009Systematic) Anke K. Bergmann, Dean R. Campagna, Erin M. McLoughlin, Suneet Agarwal, Mark D. Fleming, Sylvia S. Bottomley, and Ellis J. Neufeld. Systematic molecular genetic analysis of congenital sideroblastic anemia: evidence for genetic heterogeneity and identification of novel mutations. Pediatric Blood &amp; Cancer, 54(2):273–278, September 2009. URL: http://dx.doi.org/10.1002/pbc.22244, doi:10.1002/pbc.22244. This article has 96 citations.](https://doi.org/10.1002/pbc.22244)

[6. (Fouquet2019Genotypephenotype) Cyrielle Fouquet, Marie‐Amelyne Le Rouzic, Thierry Leblanc, Fanny Fouyssac, Guy Leverger, Laila Hessissen, Sandrine Marlin, Emmanuelle Bourrat, Mony Fahd, Emmanuel Raffoux, Jean‐Pierre Vannier, Nadja Jäkel, Ralf Knoefler, Valerie Triolo, Marlene Pasquet, Sophie Bayart, Isabelle Thuret, Patrick Lutz, Christiane Vermylen, Mohamed Touati, Christian Rose, Thomas Matthes, Bertrand Isidor, Caroline Kannengiesser, and Stephane Ducassou. Genotype/phenotype correlations of childhood‐onset congenital sideroblastic anaemia in a european cohort. British Journal of Haematology, 187(4):530–542, July 2019. URL: http://dx.doi.org/10.1111/bjh.16100, doi:10.1111/bjh.16100. This article has 20 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1111/bjh.16100)

[7. (Palmieri2013The) Ferdinando Palmieri. The mitochondrial transporter family slc25: identification, properties and physiopathology. Molecular Aspects of Medicine, 34(2–3):465–484, April 2013. URL: http://dx.doi.org/10.1016/j.mam.2012.05.005, doi:10.1016/j.mam.2012.05.005. This article has 612 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1016/j.mam.2012.05.005)

[8. (Ravindra2020Novel) Niveditha Ravindra, Rekha Athiyarath, Eswari S, Sumithra S, Uday Kulkarni, Fouzia N A, Anu Korula, Ramachandran V Shaji, Biju George, and Eunice Sindhuvi Edison. Novel frameshift variant (c.409dupg) inslc25a38is a common cause of congenital sideroblastic anaemia in the indian subcontinent. Journal of Clinical Pathology, 74(3):157–162, June 2020. URL: http://dx.doi.org/10.1136/jclinpath-2020-206647, doi:10.1136/jclinpath-2020-206647. This article has 5 citations and is from a peer-reviewed journal.](https://doi.org/10.1136/jclinpath-2020-206647)

[9. (Ducamp2019The) Sarah Ducamp and Mark D. Fleming. The molecular genetics of sideroblastic anemia. Blood, 133(1):59–69, January 2019. URL: http://dx.doi.org/10.1182/blood-2018-08-815951, doi:10.1182/blood-2018-08-815951. This article has 76 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1182/blood-2018-08-815951)

[10. (Pasquadibisceglie2021Computational) Andrea Pasquadibisceglie and Fabio Polticelli. Computational studies of the mitochondrial carrier family slc25. present status and future perspectives. Bio-Algorithms and Med-Systems, 17(2):65–78, April 2021. URL: http://dx.doi.org/10.1515/bams-2021-0018, doi:10.1515/bams-2021-0018. This article has 2 citations.](https://doi.org/10.1515/bams-2021-0018)